C&D’s Naturals Could Help Retain Orajel Customers After Benzocaine Warning
This article was originally published in The Tan Sheet
Executive Summary
Church & Dwight’s Baby Orajel Naturals could fill a potential void in the teething relief market created by FDA’s recent warning children under 2 years should not use the painkiller benzocaine.
You may also be interested in...
Church & Dwight Hopes Oral Care, Orajel Reverse Personal Care Slump
The firm seeks to make personal care a growth engine again, hoping single-dose Orajel can overcome competition and FDA concerns about benzocaine overdosing.
Church & Dwight Hopes Oral Care, Orajel Reverse Personal Care Slump
The firm seeks to make personal care a growth engine again, hoping single-dose Orajel can overcome competition and FDA concerns about benzocaine overdosing.
In Brief
Health Canada warns of benzocaine risk; Perrigo first with store-brand Mucinex; NAD enters Glaxo/Colgate toothpaste war; Sun Capital snags supplement manufacturer CornerStone; more news In Brief.